Once-weekly semaglutide 1 mg improved multiple cardiometabolic measures in patients with type 1 diabetes and may reduce long-term cardiovascular disease risk, according to a presenter. In this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results